We report a case of bone marrow infarction in a 20-year-old woman with acute lymphocytic leukemia (ALL) who underwent unrelated bone marrow transplantation (BMT). Hematopoietic engraftment occurred on day 9 and, thereafter, the patient developed acute dermal and hepatic graft-versus-host disease (GVHD). She also experienced severe arthralgia in her knee joints on day 21. Immunosuppressive therapy with prednisolone (PSL) for acute GVHD was given, and the arthralgia improved rapidly, correlating with the improvement in dermal and hepatic GVHD. Based on the laboratory findings and analysis of magnetic resonance images, she was diagnosed as having bone marrow infarction. The cause of the bone marrow infarction was thought to be acute GVHD-related microangiopathy. Keywords: arthralgia; bone marrow infarction; bone marrow transplantation; graft-versus-host disease; thrombotic microangiopathy Bone marrow infarction is a well-recognised complication in patients with sickle cell anemia and caisson disease. We report a case of bone marrow infarction of the distal femora and proximal tibiae in a patient with acute lymphoblastic leukemia (ALL) who underwent unrelated bone marrow transplantation (BMT). There has been no report of a case showing bone marrow infarction in a patient with acute graft-versus-host disease (GVHD) following BMT. The possible mechanism in this case is discussed.
1
Although the causes of bone marrow infarction have been associated with thrombosis, arteriosclerosis and infection, 1 the exact mechanisms remain unclear.
We report a case of bone marrow infarction of the distal femora and proximal tibiae in a patient with acute lymphoblastic leukemia (ALL) who underwent unrelated bone marrow transplantation (BMT). There has been no report of a case showing bone marrow infarction in a patient with acute graft-versus-host disease (GVHD) following BMT. The possible mechanism in this case is discussed.
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Case report
A 20-year-old woman was diagnosed as having ALL in June 1995 and attained a complete remission after receiving induction chemotherapy. In April 1996, she underwent unrelated BMT from an HLA-identical, ABO-matched, and sex-mismatched donor. The conditioning regimen consisted of cyclophosphamide 60 mg/kg/day for 2 days, etoposide 15 mg/kg/day for 2 days, and total body irradiation (2 Gy × 6). She also received cyclosporin A and prednisolone (PSL) for prophylaxis of GVHD. Bone marrow cells (4.36 × 10 8 /kg of the patient's body weight) were infused on day 0 without any manipulation. Successful engraftment was observed on day 9 (Figure 1 ) with the administration of granulocyte colony-stimulating factor (500 g/day).
The patient developed skin rashes on her soles and palms on day 8 and the next day the rashes rapidly progressed to the face, trunk, and all extremities. With consideration of the risk of progression to severe acute GVHD, high-dose methylprednisolone (mPSL) pulse therapy (1000 mg × 3 days) was given. The rashes improved but showed reexacerbation with tapering of mPSL. On day 21, she suddenly experienced painful, hot and swollen knee joints. These symptoms spread to both hip and ankle joints. Levels of C-reactive protein were within normal limits and X-ray films of the knee joints were normal. However, high-signal intensity areas were seen in T2-weighted magnetic resonance images (MRI) of the suprapatellar bursa of both knee and hip joints ( Figure 2 ). Based on these findings, the patient was diagnosed as having synovitis with excess fluid retention.
The arthralgia could not be well controlled with various analgesics or anti-inflammatory agents. A skin biospy showed findings consistent with typical acute GVHD. Since the patient showed wide-spread petechiae on her lower limbs and hepatic dysfunction due to GVHD on day around 40, PSL was increased to 60 mg from 40 mg, on day 49. The arthralgia improved rapidly, correlating with an improvement in the hepatic dysfunction. The skin eruption and petechiae gradually improved. The level of fibrin degradation products (FDP), which was undetectable (Ͻ2.6 g/ml) before the onset of arthralgia, increased to 7.2 g/ml and the fibrinogen level fell to 170 mg/dl from Clinical course of a 20-year-old woman with acute lymphocytic leukemia. Skin eruption due to acute GVHD occurred on her soles and palms on day 8 and rapidly extended to the face, trunk and extremities. Methylprednisolone pulse therapy initially improved these symptoms but they again excerbated with tapering of mPSL, accompanied by arthralgia. On around day 40, petechiae on her lower limbs and hepatic dysfunction developed which were thought to be caused by acute GVHD. An increased dose of prednisolone was effective in reducing the severity of these symptoms. BMT, bone marrow transplantation: CsA, cyclosporin A; CY, cyclophosphamide; TBI, total body irradiation; ETOP, etoposide; PSL, prednisolone; mPSL, methylprednisolone; RBC, red blood cell count; WBC, white blood cell count; Plt, platelet count.
351 mg/dl. After the arthralgia disappeared, the FDP level became undetectable and the fibrinogen level became normal. On day 93, T1-weighted MRI revealed focal areas surrounded by low-signal rings in both the distal femora and proximal tibiae. The focal areas were surrounded by irregular, high-signal rings on T2-weighted images. These findings were more clearly shown by MRI conducted on day 148 (Figure 3) . These results were compatible with bone marrow infarction in the distal femora and proximal tibiae.
Discussion
Arthralgia has often been reported as a complication following allogeneic BMT, correlating with infection, chronic GVHD and side-effects from treatment such as continuous intravenous administration of prostaglandin E 1 (PGE 1 ), which has been used for prophylaxis of veno-occlusive disease. [2] [3] [4] Since specific symptoms and signs of arthralgia did not resolve with antibiotics but did resolve with PSL, it is unlikely that they were caused by an infection such as chlamidial, mycoplasma or virus. The clinical features with respect to the period and location of the arthralgia differed from those seen in chronic GVHD, and autoantibodies were undetectable, thus making the possibility of autoantibodymediated arthropathy unlikely. Moreover, PGE 1 was not administered in this case. According to the MRI findings, she had bone marrow infarction and synovitis in the distal femora and proximal tibiae. The arthralgia in the knee joints appeared simultaneously with typical acute GVHD of the skin and the liver, and these symptoms resolved with the administration of PSL. This suggests that acute GVHD was the cause of the arthralgia. Since the onset of arthralgia was sudden, and changes in FDP and fibrinogen levels occurred with the onset of arthralgia, bone marrow infarction but not synovitis was thought to be the main factor involved in the arthralgia.
Bone marrow infarction is a well-recognized complication of sickle cell anemia and caisson disease. It is frequently found in long bones, most commonly in the distal femora and proximal tibiae, 1 such as in the present case. Although bone marrow infarction has been associated with thrombosis, arteriosclerosis and infection, 1 the exact mechanisms remain unclear. It has been reported, however, that several serum cytokine levels changed 5, 6 and that the expression of adhesion molecules, such as the vascular cell-adhesion molecule 1 (VCAM-1) and the vascular E-selectin (ELAM-1), was increased in target organs in some cases of acute GVHD. 7 It has also been suggested that monocytes may be important in mediating endothelial damage and activating coagulation in the course of GVHD. The wide-spread petechiae on the lower limbs suggested that there was platelet dysfunction and/or thrombotic microangiopathy in small vessels of the lower limbs.
In conclusion, it seems that GVHD-related microangiopathy is the major cause for bone marrow infarction, resulting in arthralgia. This symptom was well controlled by steroid therapy. MRI findings and coagulo-fibrinolysis examination may be helpful in diagnosing this disease when other complications influencing these factors are not present.
